home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next

From Insight to Impact: Leveraging Early Medical Affairs Engagement for Future Commercial Success

  June 11, 2024  
Xtalks, Online

In today’s pharmaceutical market, innovative new treatments with the potential to improve patients’ lives face unprecedented obstacles, including greater complexity and cost, more stringent evidence requirements to secure patient access beyond regulatory approval, a greater diversity of stakeholders and decision-makers and competition for share of voice.

Strategic, early medical affairs engagement can be the difference between a successful market entry and getting lost in the noise. Join this webinar for an insightful discussion with industry experts as they delve into the art and science of early medical affairs engagement, even when faced with limited resources.

In this webinar, the attendees will discover how small and mid-sized (SMID) companies can leverage thoughtful medical affairs planning and prioritization to drive significant impact and raise asset valuation on their journey to commercialization, including:

Effective Prioritization on a Budget: How to prioritize tactics that deliver maximum value and ensure each investment enhances early medical affairs efforts and sets the stage for future success
Navigating a Competitive Market: Strategies for driving company and scientific awareness in a crowded market, with an eye toward how to position the company and products effectively to stand out from the competition
Real-World Examples and Expert Advice: Case studies and key learnings from industry experts who have been there, understand the challenges faced by SMID companies and can offer actionable advice and best practices

Benefit from the experiences of expert speakers who have successfully navigated the complexities of early market engagement.

Register for this webinar today to learn how small and mid-sized companies can effectively prioritize and leverage medical affairs strategies to enhance asset valuation and navigate competition.

Keywords: Pharmaceutical, Pharmaceutical Industry, Pharmaceutical Marketing, Market Access, Commercialization, Medical Affairs, Marketing, Commercialization/HEOR/Market Access
Organized by: Xtalks
Invited Speakers: Anshu Sawhney, Vice President, Syneos One Medical Affairs, Syneos Health
Dr. Diego Grauman, MD, VP, Senior Medical Affairs Lead, Syneos Health
Rohan Gandhi, PhD, VP, Medical Affairs, Cloudbreak Therapeutics
Deadline for Abstracts: 2024-07-10
Registration: Free Registration
E-mail: tristan@xtalks.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.